Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Role of the tumour necrosis factor-like weak inducer of apoptosis (TWEAK)/fibroblast growth factor-inducible 14 (Fn14) axis in autoimmune thyroid disease.

Peng S, Yu X, Zhao X, Wang X, Sun X, Han C, Shan Z, Li C, Teng W.

Clin Endocrinol (Oxf). 2017 Dec;87(6):783-790. doi: 10.1111/cen.13404. Epub 2017 Jul 28.

PMID:
28636775
2.

High serum sCD163/sTWEAK ratio is associated with lower risk of digital ulcers but more severe skin disease in patients with systemic sclerosis.

Kowal-Bielecka O, Bielecki M, Guiducci S, Trzcinska-Butkiewicz B, Michalska-Jakubus M, Matucci-Cerinic M, Brzosko M, Krasowska D, Chyczewski L, Kowal K.

Arthritis Res Ther. 2013;15(3):R69.

3.

Low blood levels of sTWEAK are related to locoregional failure in head and neck cancer.

Avilés-Jurado FX, Terra X, Gómez D, Flores JC, Raventós A, Maymó-Masip E, León X, Serrano-Gonzalvo V, Vendrell J, Figuerola E, Chacón MR.

Eur Arch Otorhinolaryngol. 2015 Jul;272(7):1733-41. doi: 10.1007/s00405-014-3095-2. Epub 2014 May 26.

PMID:
24858806
4.

Tumor necrosis factor-like weak inducer of apoptosis induces inflammation in Graves' orbital fibroblasts.

Lee SJ, Kim J, Ko J, Lee EJ, Koh HJ, Yoon JS.

PLoS One. 2018 Dec 21;13(12):e0209583. doi: 10.1371/journal.pone.0209583. eCollection 2018.

5.

[Expression of TWEAK and Its Receptor CD163 in Peripheral Blood of Psoriasis Vulgaris (PV)].

Yang BC, Li MM, Deng XQ, Cao NN, Guo ZP.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2018 Sep;49(5):720-724. Chinese.

PMID:
30378333
6.
7.

Peripheral artery disease is associated with a high CD163/TWEAK plasma ratio.

Moreno JA, Dejouvencel T, Labreuche J, Smadja DM, Dussiot M, Martin-Ventura JL, Egido J, Gaussem P, Emmerich J, Michel JB, Blanco-Colio LM, Meilhac O.

Arterioscler Thromb Vasc Biol. 2010 Jun;30(6):1253-62. doi: 10.1161/ATVBAHA.110.203364. Epub 2010 Mar 18.

PMID:
20299688
8.

Impact of soluble TWEAK and CD163/TWEAK ratio on long-term cardiovascular mortality in patients with peripheral arterial disease.

Urbonaviciene G, Martin-Ventura JL, Lindholt JS, Urbonavicius S, Moreno JA, Egido J, Blanco-Colio LM.

Atherosclerosis. 2011 Dec;219(2):892-9. doi: 10.1016/j.atherosclerosis.2011.09.016. Epub 2011 Sep 16.

PMID:
21962403
9.

Alterations of soluble TWEAK and CD163 concentrations in patients with chronic heart failure.

Ptaszynska-Kopczynska K, Marcinkiewicz-Siemion M, Lisowska A, Waszkiewicz E, Witkowski M, Jasiewicz M, Miklasz P, Jakim P, Galar B, Musial WJ, Kaminski KA.

Cytokine. 2016 Apr;80:7-12. doi: 10.1016/j.cyto.2016.02.005. Epub 2016 Feb 22.

PMID:
26916171
10.

The CD163-expressing macrophages recognize and internalize TWEAK: potential consequences in atherosclerosis.

Moreno JA, Muñoz-García B, Martín-Ventura JL, Madrigal-Matute J, Orbe J, Páramo JA, Ortega L, Egido J, Blanco-Colio LM.

Atherosclerosis. 2009 Nov;207(1):103-10. doi: 10.1016/j.atherosclerosis.2009.04.033. Epub 2009 May 4.

PMID:
19473660
11.

Expression of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor, fibroblast growth factor-inducible 14 protein (Fn14), in healthy tissues and in tissues affected by periodontitis.

Kataria NG, Bartold PM, Dharmapatni AA, Atkins GJ, Holding CA, Haynes DR.

J Periodontal Res. 2010 Aug;45(4):564-73. doi: 10.1111/j.1600-0765.2010.01275.x. Epub 2010 Jun 10.

PMID:
20546112
12.

A previously unrecognized protein-protein interaction between TWEAK and CD163: potential biological implications.

Bover LC, Cardó-Vila M, Kuniyasu A, Sun J, Rangel R, Takeya M, Aggarwal BB, Arap W, Pasqualini R.

J Immunol. 2007 Jun 15;178(12):8183-94.

13.

The predictive role of sTWEAK levels in pregnant women with first-trimester vaginal bleeding.

Kasap B, Özel Türkçü Ü, Akbaba E, Sarıyıldız B, Küçük M, Turhan NÖ, Öner G, Özcan A.

J Matern Fetal Neonatal Med. 2018 Jul;31(13):1715-1719. doi: 10.1080/14767058.2017.1326097. Epub 2017 May 19.

PMID:
28462593
14.

Effect of influenza vaccine on tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in older adults.

Keshtkar-Jahromi M, Ouyang M, Keshtkarjahromi M, Almed S, Li H, Walston JD, Rios R, Leng SX.

Vaccine. 2018 Apr 12;36(16):2220-2225. doi: 10.1016/j.vaccine.2017.11.045. Epub 2018 Mar 13.

15.

TWEAK and Fn14 expression in the pathogenesis of joint inflammation and bone erosion in rheumatoid arthritis.

Dharmapatni AA, Smith MD, Crotti TN, Holding CA, Vincent C, Weedon HM, Zannettino AC, Zheng TS, Findlay DM, Atkins GJ, Haynes DR.

Arthritis Res Ther. 2011 Mar 24;13(2):R51. doi: 10.1186/ar3294.

16.

Serum levels of TWEAK and scavenger receptor CD163 in type 1 diabetes mellitus: relationship with cardiovascular risk factors. a case-control study.

Llauradó G, González-Clemente JM, Maymó-Masip E, Subías D, Vendrell J, Chacón MR.

PLoS One. 2012;7(8):e43919. doi: 10.1371/journal.pone.0043919. Epub 2012 Aug 24.

17.

The association of high sCD163/sTWEAK ratio with cardiovascular disease in hemodialysis patients.

Rusu CC, Racasan S, Kacso IM, Ghervan L, Moldovan D, Potra A, Patiu IM, Bondor C, Caprioara MG.

Int Urol Nephrol. 2015 Dec;47(12):2023-30. doi: 10.1007/s11255-015-1114-x. Epub 2015 Oct 3.

PMID:
26433887
18.

Soluble TWEAK may predict carotid atherosclerosis in treated HIV infection.

Dirajlal-Fargo S, Sattar A, Kulkarni M, Funderburg N, McComsey GA.

HIV Clin Trials. 2017 Jul;18(4):156-163. doi: 10.1080/15284336.2017.1366001. Epub 2017 Aug 22.

PMID:
28828963
19.

Serum levels of CD163 and TWEAK in patients with pulmonary arterial hypertension.

Jasiewicz M, Kowal K, Kowal-Bielecka O, Knapp M, Skiepko R, Bodzenta-Lukaszyk A, Sobkowicz B, Musial WJ, Kaminski KA.

Cytokine. 2014 Mar;66(1):40-5. doi: 10.1016/j.cyto.2013.12.013. Epub 2014 Jan 14.

PMID:
24548423
20.

Serum sCD163 levels are associated with type 2 diabetes mellitus and are influenced by coffee and wine consumption: results of the Di@bet.es study.

Rojo-Martínez G, Maymó-Masip E, Rodríguez MM, Solano E, Goday A, Soriguer F, Valdés S, Chaves FJ, Delgado E, Colomo N, Hernández P, Vendrell J, Chacón MR.

PLoS One. 2014 Jun 30;9(6):e101250. doi: 10.1371/journal.pone.0101250. eCollection 2014.

Supplemental Content

Support Center